Under the March 2026 expanded FDA guidelines, patients with established cardiovascular disease may also qualify regardless of BMI to reduce the risk of major adverse heart events
You'll reach your target therapeutic dose and lose weight at the same rate, but with far fewer side effects, which improves long-term adherence and success
EVOLUTION OF GLP-1 THERAPY Despite the considerable momentum to acclaim GLP-1 as a preferred first-line injection therapy for the treatment of type 2 diabetes, other routes of administration than injections have long been pursued
Patient coverage and premiums vary by location and plan
Its important to note that vials cannot be purchased for future treatments separately, as the pricing is designed to offer the best value when used in a single booked session
This dual approach can lead to faster fat loss, better energy utilization, and improved body composition